Pregabalin Capsule
Product Images NDC 82804-274

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 82804-274). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

82804-274-60 (Image 01)

82804-274-60 (Image 01)
This is information about Pregabalin capsules in 100mg strength, with a total of 60 capsules per pack. The capsules are white to off white in color, size "3" hard gelatin, with an orange opaque colored cap and body. Each capsule is imprinted with "SG" on the cap. The medication is manufactured by ScieGen Pharmaceuticals, Inc in Hauppauge, NY, and packaged by Proficient Rx LP in Thousand Oaks, CA. Storage instructions include keeping the medication at 25°C (77°F) and out of the reach of children. Each patient should be provided with a medication guide when dispensing. The product information includes various lot numbers and expiration dates for reference.*
FDA Label Image

Chemical Structure (Pregabalin 01)

Chemical Structure (Pregabalin 01)
FDA Label Image

Figure 1 (Pregabalin 02)

Figure 1 (Pregabalin 02)
Not available.*
FDA Label Image

Figure 2 (Pregabalin 03)

Figure 2 (Pregabalin 03)
FDA Label Image

Figure 3 (Pregabalin 04)

Figure 3 (Pregabalin 04)
Percentage of patients improved with different doses of Pregabalin: 300mg taken two times a day, 180mg taken two times a day, and 75mg taken two times a day. The text also mentions Fiscsbo and some numerical values.*
FDA Label Image

Figure 4 (Pregabalin 05)

Figure 4 (Pregabalin 05)
Percent of Patients Improved: - Pregabalin 200 mg three times a day - Pregabalin 100 mg three times a day Placebo Percent Improvement in Pain from Baseline This text provides information about the percentage of patients who experienced improvement in pain after taking Pregabalin or a Placebo. It mentions the dosage of Pregabalin and the frequency.*
FDA Label Image

Figure 5 (Pregabalin 06)

Figure 5 (Pregabalin 06)
FDA Label Image

Figure 6 (Pregabalin 07)

Figure 6 (Pregabalin 07)
FDA Label Image

Figure 7 (Pregabalin 08)

Figure 7 (Pregabalin 08)
FDA Label Image

Figure 8 (Pregabalin 09)

Figure 8 (Pregabalin 09)
This text provides information about responder rates at different percentages for a particular study or experiment. It also includes data on placebo administration at different dosages and corresponding numerical values.*
FDA Label Image

Figure 9 (Pregabalin 10)

Figure 9 (Pregabalin 10)
FDA Label Image

Figure 10 (Pregabalin 11)

Figure 10 (Pregabalin 11)
FDA Label Image

Figure 11 (Pregabalin 12)

Figure 11 (Pregabalin 12)
FDA Label Image

Figure 12 (Pregabalin 13)

Figure 12 (Pregabalin 13)
This text provides information on the percent of subjects improved with Pregabalin compared to placebo from baseline to week 16 using BOCF method.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.